GELS (Gelteq) Current Accrued Expense: $0.02 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

GELS Gelteq Ltd GELS
8 GF Score
Price $0.90
! 4 Warning Signs
View Full Analysis

What is Gelteq Current Accrued Expense?

Gelteq GELS +1.41% 8 Current Accrued Expense is $0.02 Mil as of Dec. 2025. GuruFocus rates GELS with a GF Score™ of 8/100. The stock has 4 warning signs investors should review.

Gelteq's Current Accrued Expense for the quarter that ended in Dec. 2025 was $0.02 Mil.

Gelteq's quarterly Current Accrued Expense increased from Dec. 2024 ($0.02 Mil) to Jun. 2025 ($0.07 Mil) but then declined from Jun. 2025 ($0.07 Mil) to Dec. 2025 ($0.02 Mil).

Gelteq's annual Current Accrued Expense declined from Jun. 2023 ($0.39 Mil) to Jun. 2024 ($0.31 Mil) and declined from Jun. 2024 ($0.31 Mil) to Jun. 2025 ($0.07 Mil).

Gelteq Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for Gelteq's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gelteq Current Accrued Expense Chart

Gelteq Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Current Accrued Expense
Get a 7-Day Free Trial 0.02 0.26 0.39 0.31 0.07

Gelteq Semi-Annual Data
Jun20 Jun21 Jun22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only 0.00 0.31 0.02 0.07 0.02
GELS
8GF Score
Gelteq Ltd GELS
Current Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gelteq Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of $0.02 Mil mean?
Gelteq (GELS) has a Current Accrued Expense of $0.02 Mil as of Dec. 2025. Current Accrued Expense records the total amount of accrued expenses. View historical data on Gelteq and its competitors.
Is Gelteq's Current Accrued Expense too high?
Gelteq's current Current Accrued Expense is $0.02 Mil. Overall, Gelteq has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Gelteq's Current Accrued Expense compare to APUS and BTAI?
Gelteq's Current Accrued Expense of $0.02 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Drug Manufacturers company?
A good Current Accrued Expense depends on the Drug Manufacturers industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on Gelteq and its competitors. Gelteq's current Current Accrued Expense is $0.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gelteq stock overvalued right now?
Gelteq (GELS) has a current Current Accrued Expense of $0.02 Mil. The current Current Accrued Expense is $0.02 Mil. Gelteq's overall GF Score™ is 8/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For Gelteq (GELS), the current Current Accrued Expense is $0.02 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gelteq Business Description

Address 644 Chapel Street, Level 19, South Yarra, VIC, AUS, 3141
Gelteq Ltd is a clinical and science-based company focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products, preserving the simplicity, accessibility, and efficacy of oral delivery. Its principal products are edible gels and their application in gel-based dosage forms across pets, sports, pharmaceutical, over-the-counter, and nutraceutical categories, leveraging its patent pending multiple ingredient dosage forms. The company develops and tests gel-based delivery systems for humans and pets and focuses on out-licensing its technology to companies to create products that can be manufactured and sold, while continuing to manufacture existing products under license on a white label basis.
8GF Score

Get the complete analysis for GELS

Current Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.90
Price